| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.04 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.14 | 0.5 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.13 | 0.6 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.08 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.04 |